1. Home
  2. CNTB vs MASK Comparison

CNTB vs MASK Comparison

Compare CNTB & MASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • MASK
  • Stock Information
  • Founded
  • CNTB 2012
  • MASK 2017
  • Country
  • CNTB United States
  • MASK China
  • Employees
  • CNTB N/A
  • MASK N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • MASK
  • Sector
  • CNTB Health Care
  • MASK
  • Exchange
  • CNTB Nasdaq
  • MASK NYSE
  • Market Cap
  • CNTB 44.2M
  • MASK 37.7M
  • IPO Year
  • CNTB 2021
  • MASK 2025
  • Fundamental
  • Price
  • CNTB $1.00
  • MASK $2.28
  • Analyst Decision
  • CNTB Strong Buy
  • MASK
  • Analyst Count
  • CNTB 2
  • MASK 0
  • Target Price
  • CNTB $7.50
  • MASK N/A
  • AVG Volume (30 Days)
  • CNTB 93.6K
  • MASK 74.2K
  • Earning Date
  • CNTB 05-15-2025
  • MASK 01-01-0001
  • Dividend Yield
  • CNTB N/A
  • MASK N/A
  • EPS Growth
  • CNTB N/A
  • MASK 12.16
  • EPS
  • CNTB N/A
  • MASK 0.19
  • Revenue
  • CNTB $26,033,000.00
  • MASK $4,718,055.00
  • Revenue This Year
  • CNTB N/A
  • MASK N/A
  • Revenue Next Year
  • CNTB N/A
  • MASK N/A
  • P/E Ratio
  • CNTB N/A
  • MASK $13.50
  • Revenue Growth
  • CNTB N/A
  • MASK 7.89
  • 52 Week Low
  • CNTB $0.51
  • MASK $2.13
  • 52 Week High
  • CNTB $1.73
  • MASK $4.19
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 59.56
  • MASK N/A
  • Support Level
  • CNTB $0.91
  • MASK N/A
  • Resistance Level
  • CNTB $1.12
  • MASK N/A
  • Average True Range (ATR)
  • CNTB 0.08
  • MASK 0.00
  • MACD
  • CNTB 0.01
  • MASK 0.00
  • Stochastic Oscillator
  • CNTB 59.26
  • MASK 0.00

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About MASK 3 E NETWORK TECHNOLOGY GROUP LTD

3 E Network Technology Group Ltd is a business-to-business (B2B) information technology (IT) business solutions provider. It focuses on integrated software and hardware solutions in the property management and exhibition services spaces and expanded software solutions offering to a variety of industries and sectors, including food establishments, real estate, exhibition & conferencing, and clean energy utilities. The business includes two main portfolios, namely the software development portfolio and exhibition and conference portfolio. Maximum revenue is generated from the software development portfolio.

Share on Social Networks: